| Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain K Stockstill, TM Doyle, X Yan, Z Chen, K Janes, JW Little, K Braden, ... Journal of Experimental Medicine 215 (5), 1301-1313, 2018 | 118 | 2018 |
| Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents K Stockstill, C Wahlman, K Braden, Z Chen, GL Yosten, DK Tosh, ... Pain 161 (1), 177-184, 2020 | 30 | 2020 |
| GPR183-oxysterol axis in spinal cord contributes to neuropathic pain K Braden, LA Giancotti, Z Chen, C DeLeon, N Latzo, T Boehm, ... Journal of Pharmacology and Experimental Therapeutics 375 (2), 367-375, 2020 | 22 | 2020 |
| Small molecule targeting NaV1. 7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain K Braden, HJ Stratton, D Salvemini, R Khanna Neurobiology of Pain 11, 100082, 2022 | 14 | 2022 |
| Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents TM Doyle, MR Hutchinson, K Braden, K Janes, V Staikopoulos, Z Chen, ... Journal of Neuroinflammation 17, 1-8, 2020 | 10 | 2020 |
| Activation of GPR183 by 7α, 25-dihydroxycholesterol induces behavioral hypersensitivity through mitogen-activated protein kinase and nuclear factor-κB K Braden, M Campolo, Y Li, Z Chen, TM Doyle, LA Giancotti, E Esposito, ... Journal of Pharmacology and Experimental Therapeutics 383 (2), 172-181, 2022 | 6 | 2022 |
| Development of GPR183 antagonists to treat neuropathic pain NG Latzo, K Braden, L Giancotti, Z Chen, C DeLeon, T Boehm, ... The FASEB Journal 34 (S1), 1-1, 2020 | 2 | 2020 |
| GPR183 activation in the peripheral nervous system induces behavioral hypersensitivities in rats K Oberkrom, K Braden, Z Chen, LA Giancotti, CK Arnatt, D Salvemini Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | 1 | 2023 |
| Kappa opioid receptors as modulators of novelty processing K Braden, DC Castro Neuropsychopharmacology 48 (6), 848-849, 2023 | 1 | 2023 |
| Activation of GPR183 by 7α, 25-dihydroxycholesterol induces behavioral hypersensitivity through MAPK and NF-κB K Braden, M Campolo, Y Li, Z Chen, TM Doyle, LA Giancotti, E Esposito, ... Journal of Pharmacology and Experimental Therapeutics, 2022 | 1 | 2022 |
| Novel non-opioid based therapeutics for chronic neuropathic pain TM Doyle, K Braden, CM Harada, F Mufti, RM Schafer, D Salvemini Missouri Medicine 118 (4), 327, 2021 | 1 | 2021 |
| Endogenous Opioid Peptide in Dorsal Raphe Nucleus Modulates Pain and Motivation K Braden, D De Gregorio, A Evans-Strong, DC Castro The Journal of Pain 25 (4), 12, 2024 | | 2024 |
| The Role of Nitric Oxide In 7α, 25-Dihydroxycholesterol-Induced Peripheral Sensitization K Oberkrom, K Braden, Z Chen, LA Giancotti, CK Arnatt, D Salvemini The Journal of Pain 25 (4), 6, 2024 | | 2024 |
| The Role of Midbrain Endogenous Opioids in Affect and Motivation K Braden, R Garcia-Reyes, D Castro NEUROPSYCHOPHARMACOLOGY 48, 211-211, 2023 | | 2023 |
| Synthesis and Structure-Activity Relationship of SAE-14 Analogs as G-Protein Coupled Receptor 183 Antagonists I Olayide, K Braden, D Salvemini, CK Arnatt Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Development of GPR183 antagonists to treat neuropathic pain ED Stuertz, I Olayide, K Braden, D Salvemini, CK Arnatt Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Development of GPR183 antagonists for the treatment of neuropathic pain V Kalajdzic, I Olayide, K Braden, D Salvemini, CK Arnatt Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Structure Activity Relationship and Biological Evaluation of Small Molecule Antagonists for G‐Protein Coupled Receptor Associated with Neuropathic Pain II Olayide, K Braden, N Latzo, D Salvemini, C Arnatt The FASEB Journal 36, 2022 | | 2022 |
| Investigating the Molecular Mechanisms Driving 7α, 25‐dihydroxycholesterol‐GPR183‐Induced Hypersensitivity K Braden, M Campolo, Z Chen, L Giancotti, TM Doyle, E Esposito, ... The FASEB Journal 36, 2022 | | 2022 |
| The Novel Role of GPR183-Oxysterol Signaling in Chronic Pain K Braden Saint Louis University, 2022 | | 2022 |
Daniela SalveminiProfessor of Pharmacological and Physiological Science Saint Louis University在 slu.edu 的电子邮件经过验证
